Omdia is part of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCb
Outsourcing has become increasingly important in the clinical trial industry, as pharmaceutical companies rely on clinical research organizations (CROs) to handle the complexities of clinical trials and enhance their capabilities.
Different outsourcing models, such as bespoke functional service provider (FSP) and full-service outsourcing (FSO) models, offer added flexibility. A new hybrid outsourcing model has emerged, which combines elements of FSP and FSO arrangements, providing a more adaptable approach that helps optimize clinical trial operations for drug developers.
This white paper delves into the benefits of augmenting FSO arrangements with FSP solutions to create a unique hybrid FSP/FSO model. By doing so, clinical trial performance can be maximized, and persistent challenges in clinical trial operations can be overcome.
Offered Free by: PPD
See All Resources from: PPD